Marco Brughera
Direktor/Vorstandsmitglied bei FENNEC PHARMACEUTICALS INC.
Vermögen: - $ am 30.04.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Khalid Islam | M | 67 | 15 Jahre | |
| Robert Andrade | M | 49 | 15 Jahre | |
| Simon Miles Ball | M | 45 |
Leadiant Biosciences Ltd.
 Leadiant Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences Ltd. researches, manufactures, and markets therapies for patients. The private company is based in London, UK, and has subsidiaries in Germany. The British company was founded in 1957. Antonio Gama da Silva has been the CEO of the company since 2016.
Exelead, Inc.
 Exelead, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Exelead, Inc. is a biopharmaceutical contract development and manufacturing company. The company is based in Indianapolis, IN. John Rigg has been the CEO of the company since 2014. Exelead was acquired by Merck KGaA from Leadiant Biosciences SA on February 23, 2022 for $780 million.
Leadiant Biosciences SpA
 Leadiant Biosciences SpA Pharmaceuticals: MajorHealth Technology Part of Valline Srl, Leadiant Biosciences SpA develops and manufactures pharmaceutical therapies for patients with rare diseases. The company is based in Rome, Italy. The Italian company was founded in 1957. Marco Maria Brughera has been the CEO of the company since 2011. Leadiant Biosciences was acquired by CHIESI Farmaceutici SpA on October 20, 2020. | 5 Jahre |
| Alessandro Noseda | M | 66 |
Leadiant Biosciences SpA
Leadiant Biosciences SpA Pharmaceuticals: MajorHealth Technology Part of Valline Srl, Leadiant Biosciences SpA develops and manufactures pharmaceutical therapies for patients with rare diseases. The company is based in Rome, Italy. The Italian company was founded in 1957. Marco Maria Brughera has been the CEO of the company since 2011. Leadiant Biosciences was acquired by CHIESI Farmaceutici SpA on October 20, 2020.
University of Milan
| 21 Jahre |
| Adrian Haigh | M | 64 | 10 Jahre | |
| Rostislav Raykov | M | 48 | 15 Jahre | |
| Chris Rallis | M | 70 | 13 Jahre | |
| Mike Ford | M | - |
Leadiant Biosciences SpA
Leadiant Biosciences SpA Pharmaceuticals: MajorHealth Technology Part of Valline Srl, Leadiant Biosciences SpA develops and manufactures pharmaceutical therapies for patients with rare diseases. The company is based in Rome, Italy. The Italian company was founded in 1957. Marco Maria Brughera has been the CEO of the company since 2011. Leadiant Biosciences was acquired by CHIESI Farmaceutici SpA on October 20, 2020. | - |
| Jodi Cook | M | 56 | 5 Jahre | |
| Andrea Dini | M | - |
Leadiant Biosciences SpA
Leadiant Biosciences SpA Pharmaceuticals: MajorHealth Technology Part of Valline Srl, Leadiant Biosciences SpA develops and manufactures pharmaceutical therapies for patients with rare diseases. The company is based in Rome, Italy. The Italian company was founded in 1957. Marco Maria Brughera has been the CEO of the company since 2011. Leadiant Biosciences was acquired by CHIESI Farmaceutici SpA on October 20, 2020. | - |
| Antonio Gama da Silva | M | - |
Leadiant Biosciences Ltd.
Leadiant Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences Ltd. researches, manufactures, and markets therapies for patients. The private company is based in London, UK, and has subsidiaries in Germany. The British company was founded in 1957. Antonio Gama da Silva has been the CEO of the company since 2016. | 8 Jahre |
| Surasak Lelalertsuphakun | M | 40 | 9 Jahre | |
| Mark Gowland | M | 52 | 9 Jahre | |
| Elena Tremoli | F | 78 |
University of Milan
| 44 Jahre |
| Giuseppe Bianchi | M | - |
Prassis - Istituto di Ricerche Sigma-Tau SpA
| - |
| John Landis | M | 71 |
Exelead, Inc.
Exelead, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Exelead, Inc. is a biopharmaceutical contract development and manufacturing company. The company is based in Indianapolis, IN. John Rigg has been the CEO of the company since 2014. Exelead was acquired by Merck KGaA from Leadiant Biosciences SA on February 23, 2022 for $780 million. | - |
| Raffaele Sanguigni | M | - |
Leadiant Biosciences SpA
Leadiant Biosciences SpA Pharmaceuticals: MajorHealth Technology Part of Valline Srl, Leadiant Biosciences SpA develops and manufactures pharmaceutical therapies for patients with rare diseases. The company is based in Rome, Italy. The Italian company was founded in 1957. Marco Maria Brughera has been the CEO of the company since 2011. Leadiant Biosciences was acquired by CHIESI Farmaceutici SpA on October 20, 2020. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Laura Iris Ferro | M | 72 | 12 Jahre | |
| Glenn L. Cooper | M | 71 | 4 Jahre | |
| Riccardo Rosati | M | - |
University of Milan
| 4 Jahre |
| Andrea Montevecchi | M | - |
Sigma-Tau Industrie Farmaceutiche Riunite SpA
 Sigma-Tau Industrie Farmaceutiche Riunite SpA Pharmaceuticals: MajorHealth Technology Sigma-Tau Industrie Farmaceutiche Riunite SpA engages in the provision of biopharmacological research and technology development services. It offers pharmaceutical products for therapeutic areas, such as cardiology and metabolism, gastroenterology, infectious diseases, urology, rheumatology, osteoporosis, neurology, psychiatry, and oncology. The company was founded by Emilio Cavazza and Claudio Cavazza in 1957 and is headquartered in Rome, Italy. | - |
| Sabrina di Bartolomeo | F | 52 |
Sigma-Tau Industrie Farmaceutiche Riunite SpA
Sigma-Tau Industrie Farmaceutiche Riunite SpA Pharmaceuticals: MajorHealth Technology Sigma-Tau Industrie Farmaceutiche Riunite SpA engages in the provision of biopharmacological research and technology development services. It offers pharmaceutical products for therapeutic areas, such as cardiology and metabolism, gastroenterology, infectious diseases, urology, rheumatology, osteoporosis, neurology, psychiatry, and oncology. The company was founded by Emilio Cavazza and Claudio Cavazza in 1957 and is headquartered in Rome, Italy. | 3 Jahre |
| Elmar Schnee | M | 65 | 2 Jahre | |
| Corrado Vittorelli | M | 68 |
University of Milan
| 3 Jahre |
| Joyce Victoria Bigio | F | 69 | 1 Jahre | |
| Guido Répaci | M | - |
University of Milan
| 4 Jahre |
| Silvio Broggi | M | 61 |
University of Milan
| 4 Jahre |
| Massimo Bonomi | M | 66 |
University of Milan
| 3 Jahre |
| Stefania Bariatti | F | 67 |
University of Milan
| 3 Jahre |
| Roberto Maroni | M | 69 |
University of Milan
| 3 Jahre |
| Carlo Persico | M | - |
University of Milan
| 4 Jahre |
| Antonino Amato | M | 65 |
Sigma-Tau Industrie Farmaceutiche Riunite SpA
Sigma-Tau Industrie Farmaceutiche Riunite SpA Pharmaceuticals: MajorHealth Technology Sigma-Tau Industrie Farmaceutiche Riunite SpA engages in the provision of biopharmacological research and technology development services. It offers pharmaceutical products for therapeutic areas, such as cardiology and metabolism, gastroenterology, infectious diseases, urology, rheumatology, osteoporosis, neurology, psychiatry, and oncology. The company was founded by Emilio Cavazza and Claudio Cavazza in 1957 and is headquartered in Rome, Italy. | 6 Jahre |
| Francesco Colotta | M | - |
Nerviano Medical Sciences SRL
 Nerviano Medical Sciences SRL Pharmaceuticals: MajorHealth Technology Nerviano Medical Sciences SRL provides pharmaceutical services. The company is headquartered in Nerviano, Italy. | 5 Jahre |
| Guido Guidi | M | 71 |
University of Milan
| 4 Jahre |
| Shubh Goel | M | 51 | 3 Jahre | |
| Alfio Giorgio Gritti | M | 66 |
University of Milan
| 3 Jahre |
| Carlo Brigada | M | 66 |
University of Milan
| 4 Jahre |
| Giuseppe Carlo Vegas | M | 72 |
University of Milan
| 3 Jahre |
| Stefano Orfanini | M | - |
University of Milan
| 3 Jahre |
| Miro Venturi | M | - |
Nerviano Medical Sciences SRL
Nerviano Medical Sciences SRL Pharmaceuticals: MajorHealth Technology Nerviano Medical Sciences SRL provides pharmaceutical services. The company is headquartered in Nerviano, Italy. | 3 Jahre |
| Giorgio Calesella | M | 69 |
University of Milan
| 3 Jahre |
| Ennio Bernasconi | M | - |
University of Milan
| 3 Jahre |
| Ugo di Francesco | M | 63 |
Sigma-Tau Industrie Farmaceutiche Riunite SpA
Sigma-Tau Industrie Farmaceutiche Riunite SpA Pharmaceuticals: MajorHealth Technology Sigma-Tau Industrie Farmaceutiche Riunite SpA engages in the provision of biopharmacological research and technology development services. It offers pharmaceutical products for therapeutic areas, such as cardiology and metabolism, gastroenterology, infectious diseases, urology, rheumatology, osteoporosis, neurology, psychiatry, and oncology. The company was founded by Emilio Cavazza and Claudio Cavazza in 1957 and is headquartered in Rome, Italy. | 4 Jahre |
| Marco Levi | M | 64 |
University of Milan
| 4 Jahre |
| Luciano Bonacorsi | M | - |
University of Milan
| 3 Jahre |
| Alberto Fioravanti | M | 62 |
University of Milan
| 9 Jahre |
| Piero del Soldato | M | - |
University of Milan
| 4 Jahre |
| Stefano Saccardi | M | 65 |
University of Milan
| 3 Jahre |
| Bruno Gattai | M | 65 |
University of Milan
| 4 Jahre |
| Daniele Raynaud | M | 65 |
University of Milan
| 4 Jahre |
| Enrico Colli | M | - |
University of Milan
| 3 Jahre |
| Roberto Giovanni Cera | M | 68 |
University of Milan
| 3 Jahre |
| Umberto Rosa | M | 90 |
Nerviano Medical Sciences SRL
Nerviano Medical Sciences SRL Pharmaceuticals: MajorHealth Technology Nerviano Medical Sciences SRL provides pharmaceutical services. The company is headquartered in Nerviano, Italy. | 5 Jahre |
| Paolo Melloni | M | 63 |
University of Milan
| 4 Jahre |
| Luigi Fumagalli | M | 64 |
University of Milan
| 3 Jahre |
| Giorgio Cappelli | M | 68 |
University of Milan
| 3 Jahre |
| Gianni Camisa | M | - |
University of Milan
| 4 Jahre |
| Orio Bellezza | M | 65 |
University of Milan
| 4 Jahre |
| Marco Codella | M | 64 | 6 Jahre | |
| Giorgio Luca Bruno | M | 64 |
University of Milan
| 4 Jahre |
| Claudio Descalzi | M | 69 |
University of Milan
| 4 Jahre |
| Roberto de Ponti | M | - |
Nerviano Medical Sciences SRL
Nerviano Medical Sciences SRL Pharmaceuticals: MajorHealth Technology Nerviano Medical Sciences SRL provides pharmaceutical services. The company is headquartered in Nerviano, Italy. | 2 Jahre |
| Alessandro Malacart | M | 63 |
University of Milan
| 5 Jahre |
| Giovanni Crespi | M | 65 |
University of Milan
| 4 Jahre |
| Roberto Rettani | M | 71 |
University of Milan
| 4 Jahre |
| Ananya Bhattacharya | F | - | - |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Italien | 55 | 83,33% |
| Vereinigte Staaten | 11 | 16,67% |
| Vereinigtes Königreich | 2 | 3,03% |
| Hong Kong | 2 | 3,03% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Marco Brughera
- Persönliches Netzwerk
